Display Settings:

Format

Send to:

Choose Destination
    Expert Rev Anticancer Ther. 2008 Mar;8(3):433-41.

    Controversies over the role of radiation therapy for ductal carcinoma in situ.

    Source

    Department of Radiation Oncology, 2200 Bergquist Dr, Ste #1, Lackland AFB, TX 78236, USA. bensmith@alumni.rice.edu

    Abstract

    Ductal carcinoma in situ is a premalignant disease of the breast with a rapidly rising incidence. For women with localized ductal carcinoma in situ, randomized trials have shown that radiation therapy following conservative surgery lowers the relative risk of progression to invasive disease by 60%. Therefore, following conservative surgery, radiation therapy to the breast is generally considered a reasonable standard of care. However, several clinical trials have investigated the safety of conservative surgery alone without radiation for select women with small tumors of low histologic grade excised with widely negative margins. At present, results of these trials are conflicting, and, therefore, radiation therapy is generally recommended following conservative surgery, even for patients with favorable pathologic characteristics.

    PMID:
    18366290
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Atypon

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk